Stay updated on Pembrolizumab and Lenvatinib in Melanoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab and Lenvatinib in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab and Lenvatinib in Melanoma Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    Change Detected
    Summary
    An NIH grant/contract attribution (2018) was added to the study's identifiers, and the page now shows Revision: v3.6.6, replacing the previous v3.6.5.
    Difference
    0.0%
    Check dated 2026-08-30T21:53:45.000Z thumbnail image
  4. Check
    28 days ago
    No Change Detected
  5. Check
    42 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.6.4 to v3.6.5, reflecting a newer iteration of the page content; this is a metadata-level change rather than a substantive update to study details.
    Difference
    0.0%
    Check dated 2026-08-09T07:41:26.000Z thumbnail image
  6. Check
    57 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.6.4, replacing the previous v3.6.3, indicating a newer version of the study protocol/documentation referenced on the page.
    Difference
    0.0%
    Check dated 2026-07-25T16:43:14.000Z thumbnail image
  7. Check
    78 days ago
    Change Detected
    Summary
    A new page revision label, v3.6.3, has been added (replacing v3.6.2), indicating a minor update to the page.
    Difference
    0.0%
    Check dated 2026-07-04T04:47:59.000Z thumbnail image
  8. Check
    85 days ago
    Change Detected
    Summary
    Revision updated from v3.6.0 to v3.6.2 to reflect a newer version of the page.
    Difference
    0.0%
    Check dated 2026-06-27T03:07:18.000Z thumbnail image
  9. Check
    100 days ago
    Change Detected
    Summary
    Recruitment status on the study page now shows 'No longer looking for participants,' indicating enrollment is complete. The page also adds new help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) and standardizes the Intervention/Treatment label, with the revision tag updated to v3.6.0.
    Difference
    0.2%
    Check dated 2026-06-12T15:37:53.000Z thumbnail image

Stay in the know with updates to Pembrolizumab and Lenvatinib in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and Lenvatinib in Melanoma Clinical Trial page.